The government on Monday revised its export policy related to Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), which are used in treatment of Covid-19 disease by putting them under restricted category. As per the present export policy, both the drugs are under the prohibited category.
The Directorate General of Foreign Trade, in its notification dated June 14, said, “The export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API)......has been put under restricted category with immediate effect. The export of Remdesivir Injections/API against the Advance Authorisation will not require a separate authorisation/permission.”
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.